Differentially Variable Genes of Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) represents more than 90% of all oral cancers. The etiology of the disease has been linked to genetics. To determine OSCC-associated genes, researchers usually test if the mean expression level of a gene among OSCC patients is different from that among non-OSCC patients. Recently, researchers found that genes having different variances between two biological states are also relevant to the disease of interest. To the best of our knowledge, no differential variability analysis has been conducted to investigate the genetic risk factors of OSCC yet. In this article, we identified genes differentially variable between the OSCC cases and controls by using the Brown-Forsythe test (BF test) based on two public available gene expression data sets (GSE30784 and GSE6791) from the Gene Expression Omnibus. By using the discovery set, we identified 2,904 DV gene probes, among which 456 DV probes were replicated by the validation set. Our results showed that differential variable genes could provide additional information about the mechanisms of OSCC.

[1]  Kengo Saito,et al.  Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells , 2007, International journal of cancer.

[2]  Nadarajah Vigneswaran,et al.  Epidemiologic trends in head and neck cancer and aids in diagnosis. , 2014, Oral and maxillofacial surgery clinics of North America.

[3]  César Rivera,et al.  Essentials of oral cancer. , 2015, International journal of clinical and experimental pathology.

[4]  Rosnah Binti Zain,et al.  Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance , 2017, PloS one.

[5]  Jeffrey N Myers,et al.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[7]  Renfa Lai,et al.  Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells , 2015, BioMed research international.

[8]  Iris Sawazaki-Calone,et al.  Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures , 2016, Tumor Biology.

[9]  Eduardo Mendez,et al.  Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes , 2012, PloS one.

[10]  Longke Ran,et al.  Prediction of biomarkers of oral squamous cell carcinoma using microarray technology , 2017, Scientific Reports.

[11]  D. Wong,et al.  Molecular mechanisms of head and neck cancer , 2004, Expert review of anticancer therapy.

[12]  M. Newton,et al.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. , 2007, Cancer research.

[13]  D. Wong,et al.  Disease mechanism and biomarkers of oral squamous cell carcinoma , 2006, Current opinion in oncology.

[14]  Po-Jung Huang,et al.  APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism , 2017, Nature Communications.

[15]  Matthias W. Beckmann,et al.  DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer , 2016, Nature Communications.

[16]  Adam Byron,et al.  Defining the extracellular matrix using proteomics , 2013, International journal of experimental pathology.

[17]  S. Choi,et al.  Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy , 2008, Journal of dental research.

[18]  Yang Yu,et al.  Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. , 2017, Oral oncology.

[19]  S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[20]  Lue Ping Zhao,et al.  Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma , 2008, Cancer Epidemiology Biomarkers & Prevention.

[21]  A. García-García,et al.  Genetic and molecular alterations associated with oral squamous cell cancer (Review). , 2009, Oncology reports.

[22]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[23]  Morton B. Brown,et al.  Robust Tests for the Equality of Variances , 1974 .

[24]  Andrew E. Teschendorff,et al.  Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions , 2012, Bioinform..

[25]  M. E. Johnson,et al.  A Comparative Study of Tests for Homogeneity of Variances, with Applications to the Outer Continental Shelf Bidding Data , 1981 .

[26]  H. Kitchener,et al.  Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation , 2012, Genome Medicine.

[27]  李燕 TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas , 2014 .

[28]  Shun-Fa Yang,et al.  Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression , 2017, International journal of medical sciences.

[29]  Kyoung-Won Kim,et al.  Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma. , 2015, Oncology letters.

[30]  Michael A. Charleston,et al.  Differential variability analysis of gene expression and its application to human diseases , 2008, ISMB.

[31]  Gary D. Bader,et al.  GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop , 2010, Bioinform..

[32]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.